Tenecteplase for treating acute ischaemic stroke (TA990)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 24 July 2024
Icosapent ethyl with statin therapy for reducing the risk of cardiovascular events in people with raised triglycerides (TA805)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 13 July 2022
Apixaban for preventing stroke and systemic embolism in people with non-valvular atrial fibrillation (TA275)Product type:GuidanceProgramme:Technology appraisal guidanceLast updated: 2 July 2021Published: 27 February 2013
Dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation (TA249)Product type:GuidanceProgramme:Technology appraisal guidanceLast updated: 2 July 2021Published: 15 March 2012
Edoxaban for preventing stroke and systemic embolism in people with non-valvular atrial fibrillation (TA355)Product type:GuidanceProgramme:Technology appraisal guidanceLast updated: 2 July 2021Published: 23 September 2015
Rivaroxaban for the prevention of stroke and systemic embolism in people with atrial fibrillation (TA256)Product type:GuidanceProgramme:Technology appraisal guidanceLast updated: 2 July 2021Published: 23 May 2012
Ticagrelor for preventing atherothrombotic events after myocardial infarction (TA420)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 14 December 2016
Alteplase for treating acute ischaemic stroke (TA264)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 26 September 2012
Botulinum toxin type A for treating upper or lower limb focal spasticity associated with stroke [ID768]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Dabigatran etexilate for the secondary prevention of stroke after an embolic stroke of undetermined source (ID1417)Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Invimestrocel for treating acute ischaemic stroke within 18 to 36 hours of onset TS ID 10190Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC